Ravi Kumar Jalluri

Title: Ravi Kumar Jalluri: Innovator in Pharmaceutical Compounds

Introduction

Ravi Kumar Jalluri is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for FGFR inhibition and PI3K inhibitors. With a total of 2 patents, his work is paving the way for advancements in medical treatments.

Latest Patents

Jalluri's latest patents include innovative compounds aimed at FGFR inhibition. One of his patents describes a compound with a specific structure, including various defined elements such as R, A, B, X, and Y. This compound, along with its stereoisomers, salts, and tautomers, is part of a pharmaceutical composition that can be used in treating diseases. Additionally, he has developed PI3K inhibitors, which also feature a unique structure and are described in a similar manner. These compounds are crucial for pharmaceutical compositions and their applications in disease treatment.

Career Highlights

Ravi Kumar Jalluri is currently associated with Cogent Biosciences, Inc., where he continues to innovate in the pharmaceutical sector. His expertise and dedication to research have led to the development of groundbreaking compounds that hold promise for future medical applications.

Collaborations

Throughout his career, Jalluri has collaborated with esteemed colleagues, including Mark Joseph Chicarelli and John Peter Fischer. These partnerships have enhanced his research and contributed to the success of his projects.

Conclusion

Ravi Kumar Jalluri is a distinguished inventor whose work in pharmaceutical compounds is making a significant impact in the field of medicine. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.